ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 2.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $326,000 | -12.4% | 26,210 | -3.6% | 0.00% | 0.0% |
| Q3 2016 | $372,000 | +73.8% | 27,200 | -6.2% | 0.00% | 0.0% |
| Q2 2016 | $214,000 | +36.3% | 29,000 | +18.4% | 0.00% | +100.0% |
| Q1 2016 | $157,000 | -23.4% | 24,500 | -25.3% | 0.00% | -50.0% |
| Q4 2015 | $205,000 | +81.4% | 32,800 | +69.9% | 0.00% | +100.0% |
| Q3 2015 | $113,000 | -28.0% | 19,300 | +1.6% | 0.00% | 0.0% |
| Q2 2015 | $157,000 | +149.2% | 19,005 | +149.6% | 0.00% | 0.0% |
| Q1 2015 | $63,000 | -3.1% | 7,615 | -21.3% | 0.00% | 0.0% |
| Q4 2014 | $65,000 | -31.6% | 9,675 | -45.4% | 0.00% | 0.0% |
| Q3 2014 | $95,000 | +28.4% | 17,725 | +50.0% | 0.00% | 0.0% |
| Q2 2014 | $74,000 | -3.9% | 11,815 | +20.4% | 0.00% | 0.0% |
| Q1 2014 | $77,000 | +92.5% | 9,815 | +68.8% | 0.00% | 0.0% |
| Q4 2013 | $40,000 | -82.9% | 5,815 | -54.3% | 0.00% | -80.0% |
| Q3 2013 | $234,000 | +169.0% | 12,715 | +154.5% | 0.01% | +150.0% |
| Q2 2013 | $87,000 | – | 4,996 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,331,100 | $23,281,000 | 8.28% |
| DAFNA Capital Management LLC | 191,215 | $3,344,000 | 4.89% |
| Redmile Group, LLC | 1,277,109 | $22,337,000 | 3.94% |
| BB BIOTECH AG | 3,115,371 | $54,488,000 | 3.92% |
| SECTORAL ASSET MANAGEMENT INC | 5,292,682 | $92,569,000 | 2.74% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 565,956 | $9,899,000 | 1.76% |
| OAK RIDGE INVESTMENTS LLC | 2,645,781 | $46,275,000 | 1.45% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,265,104 | $22,127,000 | 1.04% |
| Tekla Capital Management LLC | 412,965 | $7,223,000 | 0.98% |
| Private Capital Advisors, Inc. | 127,600 | $2,232,000 | 0.83% |